© 2003 BMJ Publishing Group & Association of Clinical Pathologists
REVIEW
Endocervical glandular lesions: controversial aspects and ancillary techniques
Correspondence to:
Correspondence to:
Dr W G McCluggage, Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BL, UK;
glenn.mccluggage{at}bll.n-i.nhs.uk
The incidence of malignant and premalignant endocervical glandular lesions is increasing. This review covers controversial and difficult aspects regarding the categorisation and diagnosis of these lesions. The terminology of premalignant endocervical glandular lesions is discussed because of the differences between the UK terminology and the widely used World Health Organisation classification. The morphology and histological subtypes of premalignant endocervical glandular lesions are described. Early invasive adenocarcinoma and difficulties in the diagnosis and recognition of this entity are covered, as is the measurement of early invasion within cervical adenocarcinoma. Several benign endocervical glandular lesions can mimic malignant and premalignant endocervical glandular lesions, and the distinction of these benign mimics from premalignant and malignant lesions using ancillary immunohistochemical studies is also covered. Antibodies used to distinguish between endometrial and endocervical adenocarcinoma, in the diagnosis of cervical minimal deviation adenocarcinoma of mucinous type (adenoma malignum), and in the diagnosis of cervical mesonephric lesions are also reviewed.
Abbreviations: AIS, adenocarcinoma in situ; AISM, atypical immature squamous metaplasia; CEA, carcinoembryonic antigen; CGIN, cervical glandular intraepithelial neoplasia; CIN, cervical intraepithelial neoplasia; EGD, endocervical glandular dysplasia; ER, oestrogen receptor; HCGIN, high grade cervical glandular intraepithelial neoplasia; HPV, human papillomavirus; LCGIN, low grade cervical glandular intraepithelial neoplasia; MDA, minimal deviation adenocarcinoma; MGH, microglandular hyperplasia; PAS, periodic acid Schiff; TEM, tubo-endometrial metaplasia; WHO, World Health Organisation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
